glp-1 for ckd Real-World Evidence Receptor Agonists Across the Spectrum – AJKD Blog Role of GLP1 RA in

Once-weekly preparations such as dulaglutide and extended-release exenatide produce more stable plasma concentrations with fewer peak-to-trough fluctuations compared with daily or twice-daily formulations

Daily targets: Sodium: 1,500-2,000mg from food and supplementation Potassium: 3,500-4,700mg primarily from food Magnesium glycinate: 200-300mg supplemental Calcium citrate: 500-600mg supplemental (if dietary intake is low) Vitamin D: 1,000 IU daily Implementation: Morning: magnesium glycinate (200mg) with breakfast Midday: electrolyte drink mix (one serving) or bone broth Evening: calcium citrate (500mg) with vitamin D at dinner Focus on potassium-rich foods at every meal This protocol covers the basics

KoshizawaTMorimotoTWatanabeGWatanabeTYamasakiNSawadaYet al

In a 35-year-old, this is manageable

In isolated bladder strips obtained 8 or 12 weeks after the STZ injection, the Rac1 inhibitor NSC23766 (0.1, 1, and 10 M) attenuated carbachol-induced contraction in all groups, but the extent of inhibition was greater in the diabetic and insulin-treated than the nondiabetic rats (Evcim et al

doi: 10.1007/s40618-014-0137-y 2 BlackmanAFosterGDZammitGRosenbergRAronneLWaddenTet al